BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17347234)

  • 1. Should NICE evaluate complementary and alternative medicines?
    Colquhoun D
    BMJ; 2007 Mar; 334(7592):507. PubMed ID: 17347234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should NICE evaluate complementary and alternative medicine?
    Franck L; Chantler C; Dixon M
    BMJ; 2007 Mar; 334(7592):506. PubMed ID: 17347233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary therapies and the NHS.
    Thompson T; Feder G
    BMJ; 2005 Oct; 331(7521):856-7. PubMed ID: 16223798
    [No Abstract]   [Full Text] [Related]  

  • 4. Office of Alternative Medicine supports research to evaluate effectiveness, safety, and cost of alternative and complementary treatments.
    Mast E
    ONS News; 1998 Jun; 13(6):9. PubMed ID: 10569042
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost effectiveness of complementary treatments in the United Kingdom: systematic review.
    Canter PH; Coon JT; Ernst E
    BMJ; 2005 Oct; 331(7521):880-1. PubMed ID: 16223821
    [No Abstract]   [Full Text] [Related]  

  • 6. Scientific evidence was ignored in CAM and the NHS.
    Canter PH; Ernst E
    BMJ; 2005 Oct; 331(7523):1024. PubMed ID: 16254313
    [No Abstract]   [Full Text] [Related]  

  • 7. Complementary and alternative medicine: what the NHS should be funding?
    Ernst E
    Br J Gen Pract; 2008 Mar; 58(548):208-9. PubMed ID: 18318982
    [No Abstract]   [Full Text] [Related]  

  • 8. The "Smallwood report": method or madness?
    Ernst E
    Br J Gen Pract; 2006 Jan; 56(522):64-5. PubMed ID: 16438825
    [No Abstract]   [Full Text] [Related]  

  • 9. Lords critical of training in complementary therapies.
    Duffin C
    Nurs Stand; 2000 Dec 6-12; 15(12):4. PubMed ID: 11971588
    [No Abstract]   [Full Text] [Related]  

  • 10. NICE: mostly a bad idea.
    Leaman A
    Emerg Med J; 2009 Sep; 26(9):627-8. PubMed ID: 19700572
    [No Abstract]   [Full Text] [Related]  

  • 11. Appraisals of specific treatments are needed.
    Paterson C
    BMJ; 2007 Mar; 334(7594):600. PubMed ID: 17379872
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternative therapies could save the NHS money, says report commissioned by Prince Charles.
    Dobson R
    BMJ; 2005 Oct; 331(7520):795. PubMed ID: 16210261
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE appraisals should be everybody's business.
    Wells J; Cheong-Leen C
    BMJ; 2007 May; 334(7600):936-8. PubMed ID: 17478847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Credentialing alternative medicine: a new challenge for managed care organizations.
    Burcham MR
    Manag Care Q; 1999; 7(2):39-42. PubMed ID: 10537638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research into complementary/alternative medicine: an attempt to dispel the myths.
    Ernst E
    Int J Clin Pract; 2001; 55(6):376-9. PubMed ID: 11501226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research funds for complementary medicine.
    Chen HY; Ma BY; Grant A
    Lancet; 2001 Jun; 357(9272):1982. PubMed ID: 11436226
    [No Abstract]   [Full Text] [Related]  

  • 17. Complementary and alternative medicine in asthma--safety, effectiveness and costs.
    Brutsche MH
    Swiss Med Wkly; 2002 Jun; 132(25-26):329-31. PubMed ID: 12422288
    [No Abstract]   [Full Text] [Related]  

  • 18. NICE work--providing guidance to the British National Health Service.
    Rawlins MD
    N Engl J Med; 2004 Sep; 351(14):1383-5. PubMed ID: 15459297
    [No Abstract]   [Full Text] [Related]  

  • 19. Norwegian law brings alternative medicine to the mainstream.
    Longtin R
    J Natl Cancer Inst; 2004 Feb; 96(4):254-5. PubMed ID: 14970269
    [No Abstract]   [Full Text] [Related]  

  • 20. Alternative medicine loses its champion.
    Wadman M
    Nat Med; 2007 Jan; 13(1):4. PubMed ID: 17206109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.